Possible role of adrenergic mechanisms in the systemic anti-inflammatory activity of acetic acid in rats.
D000085:Acetates / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001786:Blood Glucose; D001949:Bretylium Compounds / Q000494:pharmacology; D002351:Carrageenan / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D003714:Denervation; D004487:Edema / Q000139:chemically induced / Q000503:physiopathology; D005528:Foot; D006145:Guanethidine / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*; D015003:Yeasts
D000085:Acetates; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D001949:Bretylium Compounds; D002395:Catecholamines; D007328:Insulin; D008781:Methyltyrosines; D010643:Phenoxybenzamine; D002351:Carrageenan; D011433:Propranolol; D006145:Guanethidine